Eating Disorders and Type 1 Diabetes: Insulin Restriction Risks
Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy
Research cluster: Eating Disorders & Disordered Eating · Written by Artificial Sapiens
Eating disorders and type 1 diabetes can intersect in an especially dangerous way when food-related distress, body-image concerns, or fear of weight gain affect the use of insulin. Intentionally taking less insulin than medically needed for weight control is a recognized high-risk disordered eating behavior. It can cause diabetic ketoacidosis (DKA), worsen long-term complications, and endanger life. The problem can occur with or without a formally diagnosed eating disorder and at any body size. American Diabetes Association, 2026 NICE eating disorders guideline
A person may also have anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder (ARFID), or another eating disorder while living with type 1 diabetes, without intentionally restricting insulin. The clinical task is to understand eating patterns, motivations, diabetes treatment barriers, mental health, and immediate metabolic safety together. Assessment and treatment require collaboration between diabetes specialists and eating-disorder clinicians. ISPAD psychological care consensus
If someone with type 1 diabetes has vomiting, abdominal pain, deep or rapid breathing, marked drowsiness, fruity-smelling breath, or high ketones, seek emergency medical care immediately. DKA is a medical emergency. A person concerned about intentional insulin restriction should contact their diabetes team promptly even if they currently feel well; they should not attempt an unsupervised insulin restart or dose adjustment plan. CDC: Diabetic Ketoacidosis NICE NG69
What Do Eating Disorders and Type 1 Diabetes Have to Do With Each Other?
Type 1 diabetes is a condition of substantial insulin deficiency that requires lifelong insulin replacement. Everyday care involves making decisions about food, glucose, insulin, exercise, illness, and changing insulin needs. This sustained attention to eating can become entangled with anxiety, perfectionism, rigid rules, emotional distress, or body dissatisfaction. These psychological pathways help explain why diabetes-specific disordered eating requires attention beyond ordinary nutrition counseling. NIDDK: Type 1 Diabetes Konstantara et al., 2026
In the published literature, 'type 1 diabetes and disordered eating' (T1DE) is often used as an umbrella expression. It encompasses diagnosed eating disorders coexisting with diabetes and clinically concerning eating-related or insulin-related behaviors that interfere with diabetes management. Researchers continue to debate which exact criteria should define T1DE, and clinical practice therefore emphasizes a detailed individual assessment. A 2026 systematic review of 61 studies found substantial inconsistency in definitions and assessment instruments. Konstantara et al., 2026
The general eating-disorder framework remains relevant: persistent restriction, loss-of-control eating, purging, food avoidance, fear of weight gain, and distress or impairment warrant evaluation. But diabetes adds a treatment-related behavior—insulin restriction for weight or shape control—that ordinary eating-disorder interviews may miss. For an overview of distinct diagnoses, see Eating Disorders: Types, Symptoms, Causes, and Treatment.
What Is Insulin Restriction in Type 1 Diabetes?
In this context, insulin restriction means deliberately using less insulin than the person medically needs because of weight, shape, eating-related fears, or other disordered eating motivations. Complete omission is one form of restriction. People may struggle with this behavior alongside binge eating, rigid food rules, body-image distress, or an otherwise outwardly typical eating pattern. The term describes the motivation and clinical pattern, not just an isolated glucose reading. Insulin-Related Disordered Eating Behavior: Clarifying Terminology
Insulin is essential for the body's ability to use glucose effectively and to regulate production of ketones. Too little insulin can produce high blood glucose, dehydration, breakdown of body stores, and excess ketones, sometimes progressing to ketoacidosis. These effects explain the medical danger; they are reasons for urgent professional assessment, never a weight-management method. NIDDK: Type 1 Diabetes CDC: DKA
Is 'diabulimia' an official diagnosis?
Diabulimia is a widely recognized informal term for intentional insulin restriction associated with eating and weight concerns in people with type 1 diabetes. It is not a separate named DSM-5-TR or ICD-11 eating-disorder diagnosis. The name can also mislead, because insulin restriction does not require the recurrent binge-eating episodes or other criteria associated with bulimia nervosa. Clinical documentation may describe insulin-related disordered eating or diagnose a particular eating disorder when full criteria are met. Konstantara et al., 2026 Terminology review
Terms including T1DE, insulin omission, insulin restriction, and 'eating disorder in type 1 diabetes' are used with different meanings across publications and services. A 2025 terminology review identified many competing expressions and argued for more precise descriptions of the behavior and its motivation. For a person seeking care, the most useful clinical statement is specific: 'I am taking less insulin than I need because I am afraid of changes in weight or shape,' or another truthful description of what is happening. Terminology review
Does every missed insulin dose indicate an eating disorder?
No. Insulin can be missed or delayed because of cost, lack of access, forgotten doses, disrupted routines, diabetes distress, fear of hypoglycemia, impaired health literacy, device or pump problems, acute illness, or other circumstances. Some people change insulin according to a clinician-approved plan. The reasons matter clinically and ethically; an unexpectedly high HbA1c or a DKA admission cannot identify a motive on its own. All significant insulin gaps deserve a medical response, while assessment determines whether eating-disorder psychopathology is present. ISPAD adolescence guideline ADA Standards of Care 2026
Why This Combination Is Medically Dangerous
Diabetic ketoacidosis and acute insulin deficiency
DKA develops when insufficient insulin allows acids called ketones to accumulate. It can occur in people with type 1 diabetes during illness, insulin-delivery failures, missed insulin, or intentional restriction. DKA causes serious dehydration and metabolic abnormalities and requires hospital-level evaluation and treatment. Anyone with symptoms suggesting DKA should seek emergency care rather than waiting for a routine appointment. CDC: Diabetic Ketoacidosis
Warning signs include strong thirst, frequent urination, nausea, vomiting, abdominal pain, intense fatigue, confusion, fruity-smelling breath, and unusually deep or rapid breathing. Symptoms can progress, and a person may have dangerous ketosis before the full pattern becomes obvious. People living with type 1 diabetes should follow their established sick-day and ketone-testing instructions and obtain prompt clinical help when needed. CDC: Diabetic Ketoacidosis
Long-term vascular, nerve, kidney, and eye complications
Persistent periods of inadequate insulin can expose the body to prolonged hyperglycemia. Over time, this increases concern about eye disease, kidney disease, neuropathy, and cardiovascular health. An 11-year prospective follow-up study in women with type 1 diabetes found an association between reported insulin restriction and higher mortality and diabetes complications. As an observational study, it cannot establish that every individual's outcome is inevitable, but the signal is clinically serious. Goebel-Fabbri et al., 2008
Eating-disorder symptoms can add further complications through inadequate nutritional intake, dehydration, electrolyte disturbances, or purging. When a person has both diabetes instability and disordered eating, risk assessment must consider both medical pathways. A normal-looking body size, intermittent rather than daily restriction, or lack of an established psychiatric diagnosis cannot be used to dismiss the possibility of severe harm. NICE NG69 ISPAD psychological care
Why medical supervision matters when treatment begins
After sustained metabolic instability, clinicians may need to restore safe insulin use and nutritional intake with careful monitoring of glucose, ketones, electrolytes, fluid status, and complications. NICE specifically advises coordinated care and an individually managed transition because rapid metabolic changes can also require specialist attention, including eye and nerve assessments where indicated. These decisions belong to the treating medical team. An online article cannot supply a safe individualized insulin or food-restoration schedule. NICE NG69, diabetes section
How Common Are Eating Disorders and Insulin Restriction in Type 1 Diabetes?
Disordered eating and clinical eating disorders are more frequent in many studied groups of people with type 1 diabetes than among peers without it, particularly during adolescence and young adulthood. However, a positive symptom questionnaire, clinically diagnosed eating disorder, and intentional restriction of insulin for weight control are different outcomes. Their reported frequencies must not be combined into a single prevalence claim. ISPAD psychological care Konstantara et al., 2026
The American Diabetes Association's 2026 Standards of Care reports a median prevalence of insulin restriction for weight control of approximately 15% across cited studies and emphasizes variability in estimates. A 2026 systematic review found broad ranges, reflecting differences in samples, questions, assessment methods, and case definitions. These estimates are population findings rather than a prediction about any particular person. ADA Standards of Care 2026 Systematic review of intentional insulin omission, 2026
A separate 2026 systematic review of adult T1DE definitions brought together 61 studies and 111,208 participants overall, including comparison groups. It identified 29 methods of definition or identification and substantial inconsistency in whether insulin-related motivation was established. That heterogeneity explains why internet claims that a fixed percentage of everyone with type 1 diabetes has 'diabulimia' are unreliable. Konstantara et al., 2026
Symptoms and Warning Signs
Eating patterns and emotional experiences
Possible signs include persistent fear of weight gain, distress following insulin administration, guilt around food, rigid dietary rules, avoidance of meals, secretive or loss-of-control eating, compensatory behaviors, intense body scrutiny, or an unusually adversarial relationship with diabetes care. A person may also experience diabetes burnout, depression, anxiety, or shame about glucose readings. These features warrant compassionate questions, especially when daily functioning or metabolic safety is affected. NIDDK: Eating Disorders and the Patient With Diabetes
For some people the central experience is fear: insulin can be perceived as threatening weight or identity, and diabetes management may feel like relentless surveillance. Others experience hypoglycemia-related eating episodes, substantial diabetes distress, or frustration about repeated treatment demands. Asking what a behavior means to the person is more informative than assuming that every irregular eating pattern serves the same psychological purpose. Konstantara et al., 2026 ISPAD psychological care
Diabetes indicators that may prompt assessment
Repeated DKA episodes, unexplained persistent hyperglycemia, changes in glucose-management engagement, frequent missed appointments, or discrepancies between stated treatment and clinical measurements can raise concern. Each has multiple possible explanations. HbA1c reflects average glycemia over time and is an important clinical marker; it does not function as an eating-disorder test and cannot prove intentional insulin misuse. The clinical response is to investigate barriers and safety, not to accuse. ISPAD adolescence guideline ADA Standards of Care 2026
The absence of obvious weight loss does not exclude insulin-related disordered eating. Some people are at higher weight, others have fluctuating or stable weight, and some alternate periods of treatment adherence with restriction. Likewise, weight changes may have endocrine, medical, nutritional, or medication-related causes. Patterns of intent, distress, physical findings, growth where relevant, and the wider clinical history determine what additional assessment is needed. NICE NG69 Konstantara et al., 2026
When urgent help is needed
Urgent same-day medical review is appropriate when insulin is being missed or restricted and glucose or ketone readings are concerning, when symptoms are escalating, or when dehydration or illness complicates diabetes management. Suspected DKA—especially vomiting, abdominal pain, abnormal breathing, marked sleepiness or confusion—requires emergency evaluation. This remains true whether an eating disorder has been diagnosed or not. CDC: DKA symptoms and emergency guidance
Other critical concerns include fainting, chest pain, severe weakness, recurrent hypoglycemia, severe nutritional compromise, or acute mental health risk. Clinicians can decide whether emergency medical stabilization, a higher level of eating-disorder care, or coordinated outpatient support is appropriate. The Hub also explains broad red flags in When Is an Eating Disorder a Medical Emergency?.
Why Insulin Restriction or Disordered Eating May Develop
Weight and shape concerns interacting with insulin
Insulin treatment may change weight after initial treatment of uncontrolled diabetes, and some people interpret those changes through the lens of social appearance pressures. Fear of weight gain can become attached specifically to insulin, creating conflict between medical self-care and an eating-disorder-related goal. This explanation concerns one important pathway; it does not describe every person with type 1 diabetes who experiences disordered eating. Systematic review, 2026 Konstantara et al., 2026
Diabetes distress, burnout, and control
Type 1 diabetes demands continual attention and can carry a heavy emotional load. Persistent distress may coincide with avoidance of measurements, appointments, food-related planning, or treatment tasks. For some individuals, eating-disorder behaviors express a search for predictability or control; for others, practical treatment barriers or fear of hypoglycemia dominate. Effective assessment asks separately about body concerns, mood, diabetes self-management burden, and the function of each behavior. ISPAD psychological care
Individual and social vulnerabilities
Other associated experiences may include anxiety, depressive symptoms, prior eating-disorder history, perfectionism, interpersonal distress, bullying, stigma, traumatic experiences, and repeated comments about weight or glucose control. These factors are neither necessary nor sufficient causes. Research is often cross-sectional, so links cannot always establish the direction of influence. Respectful clinical assessment is more valuable than assigning a single causal story. Konstantara et al., 2026 Intentional insulin omission systematic review
Eating Disorder Diagnoses That Can Coexist With Type 1 Diabetes
Anorexia nervosa and atypical anorexia nervosa
Anorexia nervosa involves restriction leading to significantly low body weight in the person's developmental and medical context, together with characteristic fear of weight gain or related behaviors and disturbances in body-weight experience or evaluation. Atypical anorexia nervosa falls under other specified feeding or eating disorder (OSFED) when the anorexia psychological syndrome is present but weight is not below the threshold generally used for anorexia. Both can involve substantial medical risk. Having diabetes does not change the need for a careful psychiatric and medical assessment. NICE eating disorders guideline Anorexia Nervosa: Symptoms, Diagnosis, and Treatment
Bulimia nervosa and insulin-related compensatory behavior
Bulimia nervosa requires recurrent binge-eating episodes with loss of control and recurrent inappropriate compensatory behaviors, together with required frequency, duration, and body-image features. Clinicians may assess insulin restriction used for weight control as a diabetes-specific compensatory behavior within a broader eating-disorder picture. But the popular label 'diabulimia' alone cannot establish bulimia nervosa, and insulin restriction without binge eating does not meet its full diagnostic criteria. Konstantara et al., 2026 NICE NG69
Binge eating disorder
Binge eating disorder involves recurrent episodes of loss-of-control eating associated with clinically significant distress and without the recurrent compensatory behavior characteristic of bulimia nervosa. Diabetes may complicate evaluation because eating in response to low blood glucose is sometimes necessary medical care. Clinicians distinguish physiologically driven hypoglycemia treatment from a recurrent psychiatric binge-eating syndrome. Binge Eating Disorder: Symptoms, Diagnosis, and Treatment Konstantara et al., 2026
ARFID, OSFED, UFED, and other presentations
ARFID centers on eating avoidance or restriction producing significant nutritional or psychosocial consequences, without weight-shape motivations as its defining feature. It can occur with type 1 diabetes and affect meal regularity, medical management, and nutritional adequacy. OSFED and unspecified feeding or eating disorder (UFED) may be relevant when clinically significant symptoms do not fit one full named pattern or available information is incomplete. Pica and rumination disorder remain distinct diagnoses with their own definitions. ARFID: Symptoms and Treatment
Orthorexia is a proposed construct describing an extreme preoccupation with 'healthy' or 'pure' eating and is not a separate DSM-5-TR diagnosis. For a person with type 1 diabetes, medically indicated attention to food should not automatically be treated as pathology. Assessment turns on rigidity, distress, impairment, nutritional consequences, and the purpose of the behavior. The broader distinctions are discussed in Disordered Eating: Signs, Examples, and When to Seek Help.
How Clinicians Distinguish Disordered Eating From Other Diabetes Problems
A reliable differential evaluation considers intentional weight-motivated insulin restriction, nonintentional omissions, treatment access and affordability, knowledge gaps, device malfunctions, fear of hypoglycemia, diabetes distress, executive-function challenges, acute illness, gastroparesis or other gastrointestinal symptoms, food insecurity, and necessary adjustments advised by the diabetes team. More than one explanation can be present. The assessment is designed to discover treatable drivers rather than police or blame the person. ADA Standards of Care 2026 ISPAD psychological care
Repeated high glucose levels can indicate insufficient effective insulin for many reasons, including infection or equipment failure. Conversely, apparently normal glucose metrics cannot independently rule out restrictive eating, compensatory exercise, distress, or a developing eating disorder. Weight, HbA1c, a single behavior, and questionnaire score each convey different information. A clinician integrates medical history, biochemical data, symptoms, functional impairment, and an interview. NICE type 1 diabetes guideline Konstantara et al., 2026
Assessment and Screening
What a comprehensive assessment involves
Assessment normally begins with an immediate medical safety review, followed by a sensitive conversation about eating, insulin use, fear, body image, diabetes burden, and daily functioning. Diabetes clinicians may review glucose monitoring data, relevant insulin delivery records, episodes of DKA or severe hypoglycemia, physical symptoms, medication access, and other clinical findings. The eating-disorder team evaluates patterns of restriction, binge eating, purging, compulsive behaviors, diagnostic criteria, mental health symptoms, and social context. ISPAD psychological care NICE NG69
Clinicians may order individualized laboratory investigations, evaluate electrolytes and ketones when indicated, and examine for acute or long-term complications. Young people also require attention to growth, puberty, developmental needs, school and family context, and progressive self-management responsibility. All age groups deserve confidential, respectful questioning and an assessment free from assumptions about gender or body size. ADA children and adolescents, 2026 ISPAD psychological care
DEPS-R, general eating-disorder screeners, and diagnosis
The Diabetes Eating Problem Survey–Revised (DEPS-R) is a diabetes-specific self-report screening measure used to identify possible disordered eating. Its questions capture diabetes-related behaviors that generic measures may omit. A positive score calls for further evaluation; it does not assign anorexia, bulimia, or 'diabulimia' as a diagnosis. The 2026 review of T1DE assessment found DEPS-R commonly used, with substantial variation in definitions across studies. Konstantara et al., 2026
General-purpose instruments such as SCOFF or the Eating Disorder Examination Questionnaire may add information, but their questions can behave differently when food tracking and insulin treatment are medically necessary. A clinician may use screening alongside an interview rather than treating any score as definitive. Readers can explore the wider pathway in How Are Eating Disorders Diagnosed? Assessment and Criteria. ADA Standards of Care 2026
A conversation that makes disclosure easier
People may conceal insulin restriction because they expect criticism, loss of autonomy, hospitalization, or a punitive response. A helpful clinical question is open and specific: 'Does fear about your weight or eating ever make insulin feel difficult to take?' Follow with genuine curiosity about practical barriers and emotional experiences. If the concern is disclosed, the response should move toward safety planning and specialist referral rather than shame. NIDDK clinician discussion ISPAD psychological care
Evidence-Based Treatment and Coordinated Care
A multidisciplinary team is central
People experiencing insulin-related disordered eating typically need coordinated care from an endocrinologist or diabetes clinician, an eating-disorder-informed mental health professional, a registered dietitian with relevant expertise, and diabetes education or nursing professionals. Primary care, family members, or other specialists may contribute according to age, consent, and clinical needs. Treatment combines metabolic safety with direct attention to distressing beliefs, eating behaviors, and life context. NICE NG69 ISPAD psychological care
Treatment works best when diabetes and eating-disorder teams agree on shared goals, risk communication, monitoring plans, and who responds to deterioration. Separate programs that offer contradictory food or insulin guidance can intensify confusion. NICE advises that psychological treatment directly address insulin misuse and that teams coordinate diabetes monitoring while treatment changes are made. This is specialist-guided care, particularly when ketoacidosis or marked metabolic instability has occurred. NICE NG69
Medical stabilization and safe insulin management
Immediate treatment priorities depend on the person's condition. DKA requires emergency hospital treatment. When there is ongoing restriction without DKA, clinicians still assess urgency, glycemic patterns, ketones, electrolytes, nutritional status, and possible complications. The diabetes team develops and supervises an individualized plan for insulin treatment and nutritional rehabilitation, anticipating physiological and emotional difficulties during recovery. No fixed dose adjustment, carbohydrate target, or do-it-yourself restart schedule is appropriate for general publication. CDC: DKA NICE NG69
Psychotherapy and the limits of evidence
Cognitive behavioral approaches, family-supported interventions for appropriate age groups, and other evidence-based eating-disorder treatments can address food fears, body concerns, loss-of-control eating, and compulsive patterns. Treatment must be adapted to the specific eating-disorder diagnosis and to type 1 diabetes rather than automatically applying a generic protocol. Diabetes distress, fear of hypoglycemia, shame, and treatment adherence barriers often deserve direct psychological work. NICE NG69 ISPAD psychological care
There is a distinction between strong clinical consensus about integrated care and evidence that one named therapy reliably reverses insulin restriction in all populations. A 2026 systematic review of psychological interventions in adults found a limited, developing evidence base, with heterogeneous designs. It is therefore more accurate to recommend specialist, diagnosis-sensitive coordinated treatment than to announce a single universally proven T1DE psychotherapy. Stuckey et al., 2026 Konstantara et al., 2026
Prevention programs and psychosocial support
Prevention efforts may address body dissatisfaction, diabetes distress, critical understanding of appearance ideals, and self-compassion. A systematic review published in 2026 identified nine prevention studies; some psychological programs reduced eating-disorder risk markers, but none demonstrated a significant improvement in glycemic outcomes in the reviewed studies. This underscores both the promise and current limits of the intervention literature. D'Silva et al., 2026
Medication and higher levels of care
Medication may be appropriate for a co-occurring psychiatric condition or a particular eating-disorder diagnosis under professional supervision, but there is no established medication that specifically treats insulin restriction driven by weight and eating concerns. Higher-intensity care, including hospitalization, may be indicated by DKA, serious medical instability, inability to maintain safe insulin treatment, severe nutritional compromise, or psychiatric risk. Care level is decided clinically, with the diabetes team's participation. NICE NG69 ADA Standards of Care 2026
Adolescents, Young Adults, and Families
Adolescence brings normal developmental changes together with increasing diabetes self-management responsibilities, peer influence, and changing relationships with food and body image. Young people with type 1 diabetes should receive age-appropriate psychosocial screening during routine visits. The ADA's 2026 pediatric standards recommend screening for disordered eating and other mental health concerns and including behavioral health professionals in pediatric diabetes teams. ADA children and adolescents, 2026
Family involvement is a clinical resource when it is developmentally appropriate, collaborative, and supportive. A caregiver can help coordinate appointments, reduce blame, recognize signs of medical deterioration, and support the shared diabetes plan. Family involvement should be adapted to the young person's age, privacy, safety, and preferences; premature transfer of all diabetes tasks to an adolescent may increase distress. ISPAD psychological care ADA pediatric standards
Adults may encounter different challenges: longer diabetes duration, financial or caregiving pressures, accumulated complications, work demands, and less access to integrated eating-disorder services. Men and gender-diverse people can also develop eating disorders and insulin-related disordered eating; stereotypes about a 'typical patient' can delay recognition. A person's needs should guide care, not assumptions based on age or identity. Konstantara et al., 2026
How to Seek Help Safely
If insulin restriction is occurring or feels tempting, tell the diabetes team promptly and describe the emotional or eating-related reason as clearly as possible. If the usual clinician is unavailable, a primary care or urgent care clinician can help assess immediate risk and coordinate specialty referral. Current insulin, glucose and ketone issues should be reviewed by a qualified medical professional. Do not stop prescribed insulin, alter doses for weight control, or follow internet recovery schedules. NICE type 1 diabetes guideline CDC: DKA
A useful first appointment can focus on three practical topics: immediate metabolic safety; an eating-disorder and mental health assessment; and a coordinated referral pathway in which the diabetes and eating-disorder teams communicate. Patients can bring concerns about glucose monitoring, fear of weight change, access to food and insulin, or past negative experiences with care. The conversation can begin before the person has a name for the problem. ADA Standards of Care 2026 NIDDK clinician discussion
Friends and relatives can offer support by taking distress seriously, asking about medical safety, accompanying someone to an appointment when invited, and avoiding weight commentary or surveillance. If someone has symptoms of DKA, emergency treatment takes precedence over discussing motives. If an eating disorder is suspected, a professional evaluation can address it without requiring the person to prove that they are 'sick enough.' CDC: DKA NICE NG69
Recovery: Psychological and Metabolic Goals
Recovery means developing a safer, more sustainable relationship with diabetes treatment and eating while reducing eating-disorder psychopathology and restoring everyday functioning. Progress can involve improved consistency with medically indicated insulin, fewer medical crises, more flexible eating, reduced fear, and increased capacity to ask for help. These goals are evaluated together and individually; one favorable HbA1c result does not establish psychological recovery. NICE NG69 ADA Standards of Care 2026
Early treatment can be emotionally difficult because changes in insulin and food-related routines may evoke anxiety or fear of body changes. Clinicians should explain what to expect, monitor physical responses, and address difficult thoughts without framing treatment as a test of willpower. A compassionate, long-term plan typically includes relapse prevention, access to follow-up, and prompt re-evaluation if insulin-related concerns return. NICE NG69 ISPAD psychological care
Long-term outcome research is still limited, especially for men, gender-diverse groups, older adults, and diverse healthcare settings. Evidence about preventing symptoms cannot be assumed to prove the effectiveness of a specific treatment for severe established insulin-related disordered eating. Recovery should be measured across safety, quality of life, eating symptoms, and sustainable diabetes care. D'Silva et al., 2026 Stuckey et al., 2026
What Current Research Can—and Cannot—Tell Us
There is substantial agreement that insulin restriction motivated by disordered eating is dangerous and that integrated medical and psychological care is needed. There is less agreement on a uniform T1DE definition and on a single validated treatment pathway for all patients. The 2026 definitions review documents widely varying case definitions and instruments; separate 2026 reviews describe modest and heterogeneous intervention research. This is a clinical area where clear risk recognition exceeds the certainty of comparisons among therapies. Konstantara et al., 2026 Stuckey et al., 2026
Observational studies may identify strong associations between insulin restriction, DKA, complications, and mortality, but observational design and selection bias limit causal precision. Clinical surveys may underdetect concealed behavior and overestimate or underestimate prevalence depending on screening cutoffs. A population's sex distribution and age range can also shape reported rates. For readers, these limitations support individualized diagnosis and rapid medical attention rather than false reassurance. Goebel-Fabbri et al., 2008 Konstantara et al., 2026
Frequently Asked Questions
Is insulin restriction the same as bulimia nervosa?
No. Insulin restriction for weight control is a diabetes-specific disordered eating behavior. Bulimia nervosa requires a particular pattern of recurrent binge eating and compensatory behaviors plus other diagnostic criteria. The two may overlap, but one does not automatically establish the other. Konstantara et al., 2026
Can someone have this problem at a normal or higher body weight?
Yes. Body size alone cannot exclude insulin restriction, a co-occurring eating disorder, or serious metabolic risk. A person may have stable, fluctuating, or changing weight. Clinical attention focuses on the motivation and pattern of behavior, medical findings, and distress. NICE NG69
Can someone have an eating disorder in type 1 diabetes without missing insulin?
Yes. Food restriction, binge eating, ARFID, purging, compulsive exercise, and other disordered eating behaviors can occur while prescribed insulin is being taken. Appropriate assessment identifies the particular syndrome and the way diabetes affects its management. ISPAD psychological care
Does high HbA1c prove intentional insulin restriction?
No. HbA1c summarizes average glucose exposure and can be elevated for many reasons, including barriers to care, changing insulin needs, illness, and treatment difficulties. It does not reveal a person's psychological motivation. A sensitive assessment and clinical review are needed. ADA Standards of Care 2026
What if I am afraid that restarting insulin will change my weight?
Tell a clinician with expertise in type 1 diabetes and eating disorders about that fear. Specialists can address the psychological concern while developing a medically monitored plan. The physiological risks of insufficient insulin require attention; insulin and nutritional transitions should be individualized rather than improvised. NICE NG69
Should families watch every dose or every meal?
Support should be tailored to age, immediate clinical risk, consent, and the treating team's plan. Collaborative support, reliable access to care, and compassionate communication are more useful than blame. For youth, shared management often evolves gradually with development. ADA pediatric standards 2026 ISPAD psychological care
Can a screening questionnaire diagnose diabulimia?
No. A diabetes-specific questionnaire such as DEPS-R can signal the need for assessment. It does not establish a formal eating-disorder diagnosis, and 'diabulimia' itself is not a separate DSM-5-TR or ICD-11 diagnosis. Konstantara et al., 2026
Can continuous glucose monitoring identify an eating disorder?
Glucose monitoring can reveal clinically important patterns and support safer diabetes management, but it cannot establish intent or diagnose a psychiatric disorder. Clinicians review patterns alongside insulin-delivery history, access barriers, symptoms, and an interview. ISPAD adolescence guideline
How urgent is it to get help?
Suspected DKA is an emergency. Intentional insulin restriction also warrants prompt contact with a diabetes clinician even without DKA symptoms, because risk can escalate and treatment requires coordinated care. CDC: Diabetic Ketoacidosis NICE NG69
Related Articles
References
American Diabetes Association Professional Practice Committee. (2026). 5. Facilitating Positive Health Behaviors and Well-Being to Improve Health Outcomes: Standards of Care in Diabetes—2026. Diabetes Care. https://doi.org/10.2337/dc26-S005
American Diabetes Association Professional Practice Committee. (2026). 14. Children and Adolescents: Standards of Care in Diabetes—2026. Diabetes Care. https://doi.org/10.2337/dc26-s014
Centers for Disease Control and Prevention. (2024). Diabetic Ketoacidosis. CDC official guidance
D'Silva, N., et al. (2026). Efficacy of interventions to prevent eating disorders in people with type 1 diabetes: A systematic review. Journal of Eating Disorders, 14, Article 2. https://doi.org/10.1186/s40337-025-01460-2
de Wit, M., et al. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Psychological care of children, adolescents and young adults with diabetes. Pediatric Diabetes, 23(8), 1373–1389. https://doi.org/10.1111/pedi.13428
Goebel-Fabbri, A. E., et al. (2008). Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care, 31(3), 415–419. https://doi.org/10.2337/dc07-2026
Gregory, J. W., et al. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence. Pediatric Diabetes, 23, 857–871. https://doi.org/10.1111/pedi.13408
Konstantara, E., et al. (2026). A narrative systematic review of definitions and diagnostic criteria for disordered eating and eating disorders in type 1 diabetes. Diabetologia, 69, 2712–2740. https://doi.org/10.1007/s00125-026-06805-3
National Institute of Diabetes and Digestive and Kidney Diseases. Type 1 Diabetes. NIDDK official resource
National Institute of Diabetes and Digestive and Kidney Diseases. Eating Disorders and the Patient With Diabetes. NIDDK professional discussion
National Institute for Health and Care Excellence. Eating disorders: recognition and treatment (NG69), including diabetes-specific recommendations. NICE NG69
National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management (NG17). NICE NG17
Stuckey, H., et al. (2026). Psychological research in eating disorders/disordered eating in type 1 diabetes: A systematic review using the NIH stage model for behavioural intervention development. Diabetic Medicine. https://doi.org/10.1111/dme.70369
Systematic review. (2026). Intentional insulin omission ('diabulimia') in patients with insulin-dependent diabetes: An eating disorder? PubMed PMID 42123251
Terminology review. (2025). Insulin-Related Disordered Eating Behavior: Clarifying Terminology. PubMed Central full text